Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HS Biopharmaceuticals is one of the largest USP-approved manufacturers and suppliers of chondroitin sulfate, glucosamine, shark cartilage powder, and related ingredients for the nutraceutical and functional foods industry. The company provides bulk raw materials primarily used in joint supplement products for humans, pets, and equine markets. It operates as the US office/affiliate of Jiaxing Hengjie Biopharmaceutical Co., Ltd., China. There are no clinical trial results since it does not develop finished drugs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HS Biopharmaceuticals.